FDA Approvals

Date Posted
Article Title
10/6/2017
First Test to Detect Zika in Blood Donations Approved

Not designed to diagnose the infection, however

9/29/2017
Verzenio Approved for Advanced Breast Cancer

The most common cancer in the United States

9/28/2017
Glucose Monitoring System Eliminates Need for Finger Pricks

Instead, sensor is implanted below skin in diabetes patients

9/14/2017
9/14/2017
Aliqopa Approved for Follicular Lymphoma

A cancer of the lymph system

9/14/2017
App to Help Treat Substance Abuse Approved

But app is not recommended for opioid dependence

8/30/2017
Pediatric Treatment Approved for 'Kissing Bug' Disease

Benznidazole sanctioned for Chagas infection

8/30/2017
Antibiotic Vabomere Approved

For complicated urinary tract infections

8/30/2017
First Gene Therapy Approved in U.S.

For certain people with blood/bone marrow cancer

8/17/2017
8/4/2017
Mavyret Approved for Hepatitis C

A chronic viral infection of the liver

8/3/2017
New Treatment Approved for Acute Myeloid Leukemia

Vyxeos combines two previously approved drugs

8/2/2017
Imbruvica Approval Expanded to Include Graft Versus Host Disease

A deadly condition that affects some stem cell patients

8/1/2017
Idhifa Approved for Some With Acute Myeloid Leukemia

For adults with specific genetic mutation

7/20/2017
MRI Approved for Young Infants in Intensive Care

Device designed for neonatal brain and head imaging

7/18/2017
Nerlynx Approved to Help Prevent Breast Cancer's Return

Drug is designed to block cancer-fueling enzymes

5/24/2017
New Drug Approved for All Cancers With Genetic Marker

First medication sanctioned for any cancer, regardless of origin

5/22/2017
Actemra Approved for Certain Blood Vessel Inflammation

Drug will treat adults with a condition called vasculitis

5/18/2017
Kalydeco Approval Widened for More Types of Cystic Fibrosis

Laboratory evidence used to expand approval

5/15/2017
New Device Approved for Esophageal Birth Defect

Condition affects 1 in 2,500 babies in U.S.